logo


You're contacting media contact of this press release

Title: Personal-Fitness.org Publishes Review of CoreAge Rx and Its Expanding Telehealth Wellness Treatment Offerings

Wichita Falls, TX, United States, 2nd May 2026 - CoreAge Rx, a LegitScript-certified telehealth provider focused on physician-guided wellness and metabolic support, has been featured in a newly published article on Personal-Fitness.org examining the company’s recently expanded portfolio of wellness and longevity-focused therapies.The article provides a detailed overview of CoreAge Rx’s newly introduced treatment options, including Sermorelin therapy, NAD+ Nasal Spray, and NAD+ Injectable, while also evaluating the platform’s fully digital healthcare model and broader positioning within the evolving telehealth sector.According to the article, the expansion reflects a growing trend toward personalized, remote-access wellness treatments designed to support energy, recovery, cognitive performance, and healthy aging under physician supervision.The feature outlines how CoreAge Rx integrates the therapies into its online care ecosystem, enabling patients to complete health assessments, receive physician evaluations, and obtain approved prescriptions without in-person clinic visits.Among the treatments highlighted is Sermorelin therapy, which the article describes as a growth hormone-releasing hormone (GHRH) therapy designed to stimulate the body’s natural production of human growth hormone (HGH). The review notes that Sermorelin supports increased insulin-like growth factor 1 (IGF-1) levels, which are associated with metabolism, muscle development, and bone health.The article also discusses the platform’s NAD+ Nasal Spray, presented as a formulation designed to support cellular energy and cognitive function through intranasal delivery. According to the publication, the nasal delivery method bypasses the digestive system to allow faster absorption while supporting focus, mental...


This press release is issued by King Newswire

Email Information